Impact of FDA’s Guidance on Antimicrobial Use in Livestock
Antimicrobial resistance (AMR) is one of the most pressing global public health challenges. The widespread use of antibiotics in livestock and food production systems has
Latest News
Comparing FDA, EFSA, and WHO Policies on Antimicrobial Use in Food Production
Antimicrobial resistance (AMR) is one of the most pressing global public health challenges. The widespread use of antibiotics in livestock and food production systems has
FDA Approval Pathways for Antimicrobial Drugs
Introduction Antimicrobial resistance (AMR) is one of the most pressing global health challenges. As bacteria evolve to resist existing treatments, the need for new antimicrobial
Using Patent Intelligence to Identify Emerging Technology Trends
In today’s innovation-driven economy, organizations must anticipate technological shifts to remain competitive. Patent intelligence has emerged as a powerful strategic tool that enables companies, research
Biodegradable Materials and the Future of Sustainable Chemistry
Introduction The growing environmental impact of conventional plastics and synthetic materials has intensified the search for sustainable alternatives. Traditional plastics, derived mainly from petrochemical sources,
Claim Drafting Strategies: How to Balance Scope and Enforceability
🔹 Introduction: Why Claim Drafting Is the Heart of Patent Value A patent’s real power lies in its claims, not just the invention description Overly
Freedom to Operate (FTO) in Pharma: Why Skipping It Can Cost Millions
In pharma, innovation doesn’t fail only in the lab.Many promising products fail at launch because of patent roadblocks that could have been avoided early. This
Service Robots vs Industrial Robots: Which Is Right for Your Business?
🔹 Introduction Robots are no longer limited to factory floors. From hospitals and hotels to warehouses and retail stores, businesses are adopting robots to improve
The Rise of Immune Engagers: Strategic Implications for Pharma R&D and Licensing
The landscape of oncology is undergoing a profound transformation driven by immunotherapy innovation. Over the past decade, immune checkpoint inhibitors, CAR-T therapies, and antibody-drug conjugates